Production and Utilization of Monoclonal Antibodies against Brucella melitensis Rev1 Surface Antigens in Brucellosis Diseases

Similar documents
Epitope Mapping of the Brucella melitensis BP26 Immunogenic Protein: Usefulness for Diagnosis of Sheep Brucellosis

Enzootic Bovine Leukosis: Milk Screening and Verification ELISA: VF-P02210 & VF-P02220

Bovine Brucellosis Control of indirect ELISA kits

Sera from 2,500 animals from three different groups were analysed:

Sensitivity and specificity of an indirect enzyme-linked immunoassay for the diagnosis of Brucella canis infectionindogs

Diurnal variation in microfilaremia in cats experimentally infected with larvae of

Cattle Serologically Positive for Brucella abortus Have Antibodies

Vaccine. Diagnostic and Vaccine Chapter. J.H. Wolfram a,, S.K. Kokanov b, O.A. Verkhovsky c. article info abstract

The Effect of Enzyme Treatments on Brucella abortus Cell Walls

Monoclonal Antibodies Passively Protect BALB/c Mice against Burkholderia mallei Aerosol Challenge

Surveillance of animal brucellosis

INFECTION AND IMMUNITY, July 2000, p Vol. 68, No. 7. Copyright 2000, American Society for Microbiology. All Rights Reserved.

Immune reactivity of Brucella melitensis vaccinated rabbit serum with recombinant Omp31 and DnaK proteins

Indirect Enzyme-Linked Immunosorbent Assay for Detection of Brucella melitensis-specific Antibodies in Goat Milk

II. MATERIALS AND METHODS

EXPRESSION OF BACILLUS ANTHRACIS PROTECTIVE ANTIGEN IN VACCINE STRAIN BRUCELLA ABORTUS RB51. Sherry Poff

Development and Characterization of Mouse Models of Infection with Aerosolized Brucella melitensis and Brucella suis

Inactivation of Burkholderia mallei in equine serum for laboratory use.

Evaluation of Different Antigens in Western Blotting Technique for the Diagnosis of Sheep Haemonchosis

Control And Preventive Study Of Brucellosis By Using Lipopolysacharide Sub Unit Vaccine Brucella abortus Strain S-19

Immunogenecity of a Brucella abortus S19 Glyco-conjugate Vaccine Consisting of Lipo-polysaccharide and Outer Membrane Protein in Cattle Calves

Immunological Response of Awassi Sheep to Conjunctival Vaccination against Brucellosis Disease in Mount Lebanon

Radial Immunodiffusion Test with a Brucella Polysaccharide Antigen for Differentiating Infected from Vaccinated Cattle

The Use of Homologous Antigen in the Serological Diagnosis of Brucellosis Caused by Brucella melitensis

Cercetări bacteriologice, epidemiologice şi serologice în bruceloza ovină ABSTRACT

DISEASE DETECTION OF BRUCELLOSIS IN GOAT POPULATION IN NEGERI SEMBILAN, MALAYSIA. Abstract

Received 27 November 1995/Returned for modification 14 March 1996/Accepted 8 April 1996

Diagnosis of Heartworm (Dirofilaria immitis) Infection in Dogs and Cats by Using Western Blot Technique

PCR detection of Leptospira in. stray cat and

Overview. There are commonly found arrangements of bacteria based on their division. Spheres, Rods, Spirals

Fluoroquinolones ELISA KIT

Available online at journal homepage:

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

SUPPLEMENTARY INFORMATION

allowing distinction between A>M and M>A antigens (5), a

Fluorescence polarization assay for diagnosis of human brucellosis

COMPARISON OF DIFFERENT SEROLOGICAL ASSAYS FOR THE DIFFERENTIAL DIAGNOSIS OF BRUCELLOSIS

Presentation Outline. Commercial RVF vaccines. RVF Clone 13 performance in the field. Candidate RVF vaccines in the pipeline

Evaluation of combined vaccines against bovine brucellosis

Int.J.Curr.Microbiol.App.Sci (2017) 6(11):

Salmonella. Serological. Salmonella. food poisoning. Use of pasteurized milk and milk products Improvement of hygiene. Proper storage of foods

Received 7 December 1998/Returned for modification 5 April 1999/Accepted 22 June 1999

Classificatie: intern

1. INTRODUCTION. and 1 Saleh, M.S. El-Ayouby. veterinary Medicine, Benha University, Egypt. A B S T R A C T

Survey of the seroprevalence of brucellosis in ruminants in Kosovo

and other serological tests in experimentally infected cattle

The Salmonella. Dr. Hala Al Daghisatni

Received 20 August 2004/Returned for modification 9 September 2004/Accepted 15 October 2004

BALB/c Mice against Virulent Strains of Brucella abortus,

Identification of Bartonella-Specific Immunodominant Antigens Recognized by the Feline Humoral Immune System

Revaccination with a reduced dose of Brucella abortus strain 19 vaccine of breeding cows in the Pampas region of Argentina

CAPRINE AND OVINE BRUCELLOSIS (excluding Brucella ovis)

Brucellosis situation in Mongolia and Result of Bovine Brucellosis Proficiency Test

Neha Dabral 1, Martha-Moreno-Lafont 1,2, Nammalwar Sriranganathan 3, Ramesh Vemulapalli 1 * Abstract. Introduction

Purification of Nonlipopolysaccharide Antigen from Brucella abortus

Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection

Received 19 December 2002/Returned for modification 31 January 2003/Accepted 19 February 2003

National Research Center

Enzyme immunoassay for the qualitative determination of antibodies against Toxocara canis in human serum or plasma

ELECTROPHORETIC ANALYSIS OF SERUM PROTEINS OF BIRDS AND MAMMALS

Lack of a Role for Natural Killer Cells in Early Control of Brucella abortus 2308 Infections in Mice

Presence of extended spectrum β-lactamase producing Escherichia coli in

Serologic Responses and Kinetics of B. abortus Biotype 1 Infection in Sprague-Dawley Rats

Isolation of antibiotic producing Actinomycetes from soil of Kathmandu valley and assessment of their antimicrobial activities

OIE Reference Laboratory Reports Activities

POST SCREENING METHODS FOR THE DETECTION OF BETA-LACTAM RESIDUES IN PIGS.

BIOLACTAM. Product Description. An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity

EVALUATION OF THE SENSITIVITY AND SPECIFICITY OF THE EHRLICHIA CANIS DIAGNOSTIC TEST: Anigen Rapid E.canis Ab Test Kit

Visit ABLE on the Web at:

Supporting Online Material for

Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate

Recent Topics of Brucellosis

Gliding Motility Assay for P. berghei Sporozoites

Title. Author(s)WANG, Chun-Tshen. CitationJapanese Journal of Veterinary Research, 39(2-4): 10. Issue Date DOI. Doc URL.

CHAPTER - I INTRODUCTION

Received 15 September 2008/Returned for modification 20 October 2008/Accepted 28 October 2008

A rapid test for evaluating B. melitensis infection prevalence in an Alpine ibex (Capra ibex) reservoir in the French Alps

Food safety related to camelids products: Brucellosis and its impact on Public Health and the consumers as an example

Medical Bacteriology- Lecture 14. Gram negative coccobacilli. Zoonosis. Brucella. Yersinia. Francesiella

The Search For Antibiotics BY: ASLEY, ELIANA, ISABELLA AND LUNISCHA BSC1005 LAB 4/18/2018

Taxonomic Position in the Genus Brucella of the Causative Agent of Canine Abortion

Mastitis cows and immunization

Country Report Malaysia. Norazura A. Hamid Department of Veterinary Services, Malaysia

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Tel: Fax:

Case Study Brucellosis: 2001 & Case Study Brucellosis: 2001 & Case Study Brucellosis: 2001 & Case Study Brucellosis: 2001 & 2002

Brucellosis in Ringed Seals and Harp Seals from Canada

Antigenic Cross-reactivity among Haemonchus contortus, Oesophagostomum columbianum and Trichuris ovis of Goat

Received 24 September 2001/Returned for modification 16 December 2001/Accepted 27 January 2002

Specific Enzyme-Linked Immunosorbent Assay for Detection of Bovine Antibody to Brucella abortus

EPIDIDYMITIS IN RANGE

Bovine Mastitis Products for Microbiological Analysis

Efficacy of Brucella abortus vaccine strain RB51. compared to the reference vaccine Brucella abortus

ENVIRACOR J-5 aids in the control of clinical signs associated with Escherichia coli (E. coli) mastitis

the Lectin Pathway of Complement in

Brief Report THE DEVELOPMENT OF VANCOMYCIN RESISTANCE IN A PATIENT WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION

Himani B. Pandya, Ph.D (medical microbiology) Tutor, S.B.K.S Medical College and Research Institute Gujarat, INDIA

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill

Identification of the agent: Serological tests: Requirements for vaccines:

Transcription:

JOURNAL OF PURE AND APPLIED MICROBIOLOGY, September 2013. Vol. 7(3), p. 2123-2127 Production and Utilization of Monoclonal Antibodies against Brucella melitensis Rev1 Surface Antigens in Brucellosis Diseases Neda Bayat 1, Saeed Heidari-keshel 1, 2, Mostafa Rezaei-Tavirani 1, Maryam Ebrahimi 1 and Golam Reza Behrouzi 1 * 1 Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2 Department of Tissue Engineering, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. (Received: 18 October 2012; accepted: 21 December 2012) By immunizing mice with killed whole bacterial cells of Brucella Melitensis Rev1 a panel of four hybridomas producing monoclonal antibodies (mab) specific for the surface antigens of this bacterium were produced. ELISA was used to screen the hybridoma supernatants. Immunoblots of the cell extract indicated that tow mab were specific for S- LPS (BOX-1, BOX-2, and tow others were reactive with major outer membrane proteins (OMP) (Box-3, Box-4). The OMP recognized by these antibodies were the proteins with molecular masses of 22-25 kda (Box-3, Box-4) and 30-33 kda (Box-1). None of the three mab including Box-2, Box-3 and Box-4 cross reacted with any other bacteria close to Brucella melitensis, but Box-1 cross reacted with B. abortus S19 and B. suis. By using cell extract and killed whole cell Ag in ELISA, it was indicated that all mab except Box- 1 have better reactivity with cell extract Ag, but Box-4 mab reacted with killed whole cell Ag better than cell extract Ag. We utilize the isolated antibodies (Box4) in lateral flow test. Key words: Brucella Melitensis, Hybridomas, Monoclonal antibodies. Brucellosis is a chronic zoonotic disease resulting in undulant fever in humans and abortion and /or infertility in affected animals 1. Brucellae are small, non-motile, gram-negative cocobacilli, which cause disease in a variety of mammals 2. There are six species of Brucella that are currently recognized based on their host-specificity. They include Brucella abortus (cattle), B. melitensis (goats), B. suis (hogs), B. canis (dogs), B. ovis (sheep), and B.neotomae (wood rat) 3. Recently, Brucella has been recovered from a variety of marine mammals including cetaceans (e.g. dolphins), seals, and otters. Though the organisms recovered from these marine mammals do not fit into the nomen classification by the currently available laboratory identification scheme, they have been confirmed to be Brucella, but probably * To whom all correspondence should be addressed. Tel.: +982122714248; Fax: +982122714248; E-mail: afshinbehrouzi@gmail.com deserve a new species designation. There is at least one report of human exposure to Brucella isolated from a sea mammal 4. Brucella organisms can be phenotypically categorized based on their colony morphology into smooth, rough, and intermediate/ mucoid 2. Organisms characterized as smooth contain the O-antigen (O-polysaccharide composed of perosamine polymers) on their lipopolysaccharide (LPS); true rough organisms do not contain O-antigen. In general, smooth Brucella are more virulent than their rough counterparts 2. B. canis and B. ovis are the only species of Brucella that naturally occur in the rough form, and yet are still pathogenic in their host species 2. All other 4 nomen species naturally occur in the smooth form. The newly discovered marine isolates all appear to be smooth. Smooth Brucella organisms are better able to survive intracellularly than do their rough counterparts. Therefore, smooth lipopolysaccharide (S-LPS)

2124 BAYAT et al.: Rev1 MONOCLONAL ANTIBODY PRODUCTION probably plays a significant role in pathogenesis. Experiments suggested that in Brucella melitensis strains, the expression of a fatty tissue called O-polysaccharides (OPS) on the outer membrane of the bacterium controls whether the bacterium will look smooth or round 5. The absence of these O-polysaccharide chains turns the organism into a rough variant. This layer is important in identifying whether a pattern of species-specific flagellar gene inactivation s and flagellum gene clusters exist, because this would give a better understanding of host specificity and virulence. The need for these species to survive in a species-specific environment provides an explanation that the adaptation of the Brucella species requires an intracellular life-style in a protected and more stable local environment or niche that provides a constant supply of nutrients 6. Currently, little is known about their chromosomal exchange, and there is no evidence of plasmids or bacteriophages in these species. So product the specific antibodies against S-PLS of B. melitensis and utilizing it in lateral flow tests for detection of brucellosis causes B. melitensis in sheep and gout of remote villages can help to our, that we control of brucellosis. There is a report that it is possible that Brucella use as biological weapons. MATERIALS AND METHODS Bacterial strains Brucella strains used were B.melitensis Rev. 1 (biovar 1, ELISA vaccine strain). They were from the Brucella Culture Collection, maintained at INRA,Nouzilly, France by J. M. Verger and M. Grayon. Bacterial cultures were grown on Trypticase Soy Agar (TSA) (biomerieux, Marcy L Etoile, France) supplemented with yeast extract (TSAYE medium) (Difco Laboratories, Detroit, MI) 0.1 % w/v. Strains were checked for purity, species and biovar characterisation by standard procedures. Antigens Cell envelope fraction (CEF), cell-wall fraction (C W), sodium dodecyl sulphateinsoluble(sds-i) and -soluble (SDS-S) cell-wall fractions from B. melitensis Rev1 (S) and 0- polysaccharide (0-PS) from B. melitensis Rev1 were prepared as described previously [7-8]. Whole cell lysates of the Brucella biovars were prepared from 24-h slant cultures (c. 10' bacteria) harvested in 3 ml of sterile H20 and centrifuged at 5000 g for 30 s. The pellets were lysed by heating for 10 min at 100 C in 500 µl of modified Laemmli sample buffer (62.5 mm Tris, SDS 2%, 100 mm DTT, glycerol lo%, ph 6.8) and dissolved proteins were further analyzed by SDS-PAGE and immunoblotting. Mice, immunisations and hybridomas Groups of five 8-week-old female BALB/ c mice were inoculated intraperitoneally with lo7 cfu of B.melitensis strain Rev. 1. Mice were bled 5 weeks later to evaluate antibody responses to CW and CEF antigens. Three months after challenge mice infected with B.melitensis strain Rev1 were boosted intravenously with 30 µg of partially purified CEF and on the following day intraperitoneally with 300µg of CPE and intravenously with 40µg of CEF. Two days after the last booster injection, spleen cells were fused with cells of the SP2/0 myeloma cell line at a ratio of 5:l. After fusion, cells were suspended in selective hypoxanthine-aminopterin-thymidinecontaining medium and seeded in 96-well microtitration plates at 10 5 splenocytes /well. Anti- Brucella hybridomas (tissue culture supernates diluted 1 in 3) were screened by ELISA with CW and CEF as antigens. Hybridomas of interest were cloned by the limiting-dilution technique. ELISA ELISA on CEF, CW, SDS-I, SDS-S and 0- PS antigens and on B. melitensis Rev1 whole or sonicated bacteria was performed as described previously 9, 10. Antigens were coated overnight at room temperature on microtitration plates at a concentration of 1µg/well in phosphate-buffered saline (PBS) for all antigen preparations except for 0-PS which was at a concentration of 3 µg/ml. Binding of mouse polyclonal antibodies (sera serially diluted in PBS containing Tween20,0.05%; PBS-T) or MAbs (hybridoma supernates diluted 1 in 3 or serially diluted in PBS-T) was detected by HRP-conjugated goat anti-mouse immunoglobulins (BioRad, France) diluted 1 in 3000 in PBS-T. Substrate solution for detecting peroxidase activity was 4 mm H 2 0 2 and 1 mm TMB (3, 3, 5, 5 - Tetramethylbenzidine) in 50 mm sodium citrate, ph 4.2. Absorbance values at 450nm were recorded with an automatic ELISA reader (Phomo Autobio labtech, china) after add 1M H 2 SO 4.

BAYAT et al.: Rev1 MONOCLONAL ANTIBODY PRODUCTION 2125 SDS-PAGE and immunoblotting techniques SDS-PAGE and immunoblotting of CW, CEF (deposits of 60 µg), or whole cell lysates (deposits of 20 µg) were performed as described previously [7-8]. Binding of mouse polyclonal antibodies (sera diluted 1 in 100) or MAbs (1 in 3 or serially diluted hybridoma supernates) was detected by rabbit anti-mouse immunoglobulin antiserum (diluted 1 in 500) (Nordic Immunology, Tilburg, The Netherlands) and peroxidaseconjugated protein A (diluted 1 in 1000) (Sigma). Binding of sheep polyclonal antibodies (sera diluted 1 in 100) was detected by peroxidaseconjugated rabbit anti-sheep IgG immunoglobulin s (Jackson Immunoresearch Labs, West Grove, PA, USA). Peroxidase activity was revealed with the development kit from BioRad S.A., Paris, France, containing 4-chloro-1-naphtol, according to the manufacturer s instructions. confirmed by immunoblotting of CW (Fig. 2). The antibody responses to CW were also the highest As antibody responses to CP were the highest in mice infected with B. melitensis Rev1, these mice were further used for MAb production. MAbs Tissue culture supernates from hybridomas were screened initially for the presence of antibody by ELISA with CW as coating antigens. Reactivity to 0-PS was also further monitored by ELISA. MAb specificity of ELISA positive hybridoma supernates was thereafter determined by immunoblotting with CW as antigens. Most hybridomas produced antibodies to CW (Table 1). The other CW specificities were CW12 and CW24. MAbs to the latter protein bound only to CW in ELISA and immunoblotting and were further shown to be specific for the CW with the B. melitensis Rev1. MAbs to CW31 showed high reactive-in RESULTS Antibody responses to CW in mice after infection Antibody responses in BALB/c mice to CW induced by infection by B. melitensis Rev. 1 (S) were first measured by ELISA, 5 weeks after challenge, with CW as coating antigens (Fig. 1). The highest antibody titres to CW were observed in the mice infected with S B. melitensis strains Rev. 1 (Fig. la). The antibody titres were 50-100 times lower in the mice infected with R B. melitensis Rev1. The antibody responses to CW31 were also the highest in mice infected with B. melitensis Rev1. The higher antibody responses to CW induced by infection with S B. melitensis strains Rev. 1 were Table 1. Brucella-specific hybridomas Specificity No. ELISA binding on Obtaine CW CPE 12 1 ++ + 24 8 +++ +++ 31 22 +++ + O-PS 3* - +++ Unknown 17 # - +++ *MAbs to the O-PS protein were further shown to be specific for the CPE. # Nine MAbs with unknown specificity reacted preferentially with CPE in ELISA, the others reacted preferentially with CPE. Fig. 1. Antibody reactivity measured by ELISA to B. Melitensis Rev1.CW(a) and CPE(b) antigens of sera from Balb/c mic infected with B. melitensis strains Rev1 (S)(O), H38(S)( ) or B115(R) (Δ) or B. Ovis strain 63/290(R) ( ) (5 week after challenge)

2126 BAYAT et al.: Rev1 MONOCLONAL ANTIBODY PRODUCTION Fig. 2. Antibody responses detected by immunoblotting of B. meliterzsis B115 CPE antigens with sera (diluted 1 in 100) from BALB/c mice (five mice sera for each challenge) infected with B. melitensis strains H38 (S) (Len.2 and 3), Rev. 1 (S)(Len. 4and 5) or B. ovis strain 63/290 ( R ) (Len.1) ( 5 weeks after challenge) ELISA CW (most absorbance values were > 1.5) and reacted poorly with CPE (absorbance values < 0.5) (Table 1).ELISA results were confirmed by immunoblotting, i.e. Twenty-one hybridomas were also obtained with supernates showing antibody reactivity in ELISA either on CW but which did not show antibody reactivity in immunoblotting. In addition, three hybridomas were shown by ELISA to secrete antibodies specific for 0-PS epitopes. MAbs to CW reacted in immunoblotting to CEF bands of CW also recognised by serum antibodies of sheep infected naturally with B. melitensis and infected experimentally with strain Rev1 (Fig. 4). Localization of CW31 in B.melitensis cells and fractions Reactivity of MAbs with B. melitensis cells and subcellular fractions. MAbs to CW were further used to determine localisation and presence of these CEF in other subcellular fractions, i.e., CW, SDS-I and SDS-S fractions of B. melitensis Fig. 3. Occurrence of CW12, CW24, and CW31 in Brucella species and biovars. Immunoblotting with anti-cw12 MAb V78/01B 1 O/G05, anti-cw24 MAb V78/04C 12/A12, and anti-cw31 MAb V78/05G03/H03 of whole-cell lysates from B. melitensis strains Rev.1 (lane l), 16M (2), 63/9 (3), Ether (4); B. abortus strains 544 ( 5 ), B19 (6), 86/8/59 (7), Tulya (8), 292 (9), B3196 (lo), 870 (ll), C68 (12); B. suis strains 1330 (13), Thomsen (14), 686 (15), 40 (16), 513 (17); B.neotomae strain 5K33 (18); B. ovis strain 63/290 (19); B. canis strain RM6/66 (20) Rev1. CPE were added for comparison. None of the MAbs bound to whole B. melitensis Rev1 bacteria in ELISA, but bound to sonicated bacteria indicating an exclusively intracellular localisation of these CW. MAbs to CW31 bound only to CEF and in a limited manner to CEF. Occurrence of CW31 in Brucella species and biovars By immunoblotting of whole cell lysates with the MAbs, the presence of CW31 was observed in all Brucella species and biovars, including vaccine strains B. melitensis Rev. 1 and B. abortus B 19 (Fig. 3).

BAYAT et al.: Rev1 MONOCLONAL ANTIBODY PRODUCTION 2127 DISCUSSION A previous study identified a number of protein bands by immunoblotting with CEF which discriminated antibody responses of sheep infected with B. melitensis from sheep vaccinated with Rev. 1 5. Among the CW, a 28-kDa CEF (CW31) was recognised by antibody of most infected sheep sera. As shown in the present study, antibody response patterns to B. melitensis CW in BALB/c mice infected by B. melitensis were similar to those observed in infected sheep. However, the anti- body response intensity depended on the challenge strains. The highest antibody responses to CW were observed in mice infected with S B. melitensis strains H38 (virulent) and Rev. 1 (vaccine). The antibody responses in BALB/c mice infected by R B. melitensis strain B115 and B. ovis strain 63/290 were appreciably lower. These observations are probably related to the pathogenicity and persistence of the strains used. S Brucella strains are considered to be more virulent than R strains and persist for longer in the host. Therefore, to produce MAbs of interest, spleen cells from mice infected with B. melitensis strain Rev1 were chosen for hybridoma production. In addition, these mice were boosted with CEF enriched fraction. The fact that only a limited number of hybridomas was obtained with 0-PS specificity may be due to the absence or limited content of 0-PS in the antigen preparations used for booster injections per- formed before the fusion experiment. The high immunogenicity of CW31 was reflected by the great number of CW31-specific hybridomas obtained. The other hybridomas obtained that secreted MAbs specific for CW15 and CW25 are also of interest, as CP8 and CP20 were also shown to be specific to infection status in sheep although antibody responses to these CEF were more heterogeneous than antibody responses to CW31. In next step we will utilizing CW31 Mab in lateral flow base on a competition test that gold- Mab conjugate compare with native CEF anti-body in serum or milk infection gout or sheep. ACKNOWLEDGMENTS REFERENCES 1. Acha, P., and B. Szyfres., Zoonoses and communicable diseases common to man and animals. Pan American Health Organization, Washington, D.C, 1980. 2. Corbel, M. J., and W. J. Brinley-Morgan., Genus Brucella, p. 377-388. In N. R.Krieg (ed.), Bergey s manual of systematic bacteriology, vol. 1. Williams & Wilkins,Baltimore, 1984. 3. Corbel, M. J., Brucellosis: an overview. Emerg Infect Dis. 1997; 3: 213-21. 4. Brew, S. D., L. L. Perrett, J. A. Stack, A. P. MacMillan, and N. J. Staunton., Human exposure to Brucella recovered from a sea mammal [letter]. Vet Rec. 1999; 144: 483. 5. Fernandez-Prada C.M., Zelazowska E.B., Bhattacharjee A.K., Nikolich M.P., Hoover D.L., Identification of smooth and rough forms in cultures of Brucella melitensis strains by flow cytometry. Journal Immunology Methods. 2006; 315(1-2): 162-70. 6. Chain P.S., Comerci D.J., Tolmasky M.E., Larimer F.W., Malfatti S.A., Verquez L.M., Aquero F., Land M.L., Ugalde R.A., Garcia E., Whole-genome analyses of speciation events in pathogenic Brucellae,, 2005. 7. Zygmunt MS, Debbarh HS, Cloeckaert A, Dubray G. Antibody response to Brucella melitensis outer membrane antigens in naturally infected and Rev1 vaccinated sheep. Vet Microbiol, 1994; 39: 3346. 8. Zygmunt MS, Martin J-C, Dubray G. Analysis of immune response: comparison of immunoblots after isoelectric focusing and sodium dodecyl sulfate-polyacrylamide gel electrophoresis using cytoplasmic protein extract from Brucella. FEMS Microbiol Lett 1990; 70: 263-268. 9. Cloeckaert A, de Wergifosse P, Dubray G, Limet JN. Identification of seven surface-exposed Brucella outer membrane proteins by use of monoclonal antibodies:immunogold labeling for electron microscopy and enzyme-linked immuno-sorbent assay. Infect Immun 1990; 58: 398CL3987. 10. Zygmunt MS, Cloeckaert A, Dubray G. Brucella melitensis cell envelope protein and lipopolysaccharide epitopes involved in humoral immune responses of naturally and experimentally infected sheet. J Clin Microbiol 1994; 32: 2514-2522. The authors appreciate and thankful to all the persons who assist in performing this study.